Skip to content

Shattuck Labs, Inc. STTK Unrealized gains (losses) on available-for-sale securities

Unrealized gains (losses) on available-for-sale securities at other companies

Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$74K
Vor Biopharma logo
Vor BiopharmaVOR
-$747K-74,800%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
-$893K-240%
MoonLake Immunotherapeutics logo
MoonLake ImmunotherapeuticsMLTX
$77K+103%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$122K+15.3%
Alumis Inc. logo
Alumis Inc.ALMS
-$655K-1,265%

Other financials

Income statement

See full
Revenue-
Operating income-$15.5M-8.0%
Net income-$14.8M-7.8%
EPS (diluted)-$0.13+51.9%

Balance sheet

See full
Cash & equivalents$90.4M+48.5%
Total debt$2.9M-9.5%
Total equity$95.8M+41.8%
Total assets$102.1M+32.3%

Cash flow

See full
Operating cash flow-$13.4M-11.6%
CapEx$63.0K
Free cash flow-$13.5M-12.1%

Valuation

See full
Market cap$564.45M+1,131%
Enterprise value$476.92M-4,119%
P/S564.5×+554×

Profitability

See full
Operating margin-5,266.4%-9,520pp
Net margin-4,987.4%-8,966pp
FCF margin-4,140.8%-7,144pp

Returns & leverage

See full
Return on equity-61%-8.0pp
Debt / equity0.0×
Current ratio22.1×+13.0×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax.

The official record: Shattuck Labs, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Shattuck Labs, Inc.'s unrealized gains (losses) on available-for-sale securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Shattuck Labs, Inc.'s unrealized gains (losses) on available-for-sale securities?
Shattuck Labs, Inc. (STTK) reported unrealized gains (losses) on available-for-sale securities of -$6K in Q1 2026.
How has Shattuck Labs, Inc.'s unrealized gains (losses) on available-for-sale securities changed year-over-year?
Shattuck Labs, Inc.'s unrealized gains (losses) on available-for-sale securities decreased by 200.0% year-over-year, from -$2K to -$6K.
What is the long-term trend for Shattuck Labs, Inc.'s unrealized gains (losses) on available-for-sale securities?
Over 2 years (2023 to 2025), Shattuck Labs, Inc.'s unrealized gains (losses) on available-for-sale securities has grown at a -93.3% compound annual growth rate (CAGR), from $884K to $4K.
What does unrealized gains (losses) on available-for-sale securities mean?
This metric represents the change in fair value of available-for-sale debt or equity securities that have not yet been realized through a sale. It reflects market-driven fluctuations in the value of a company's investment portfolio that are recognized in equity rather than through the income statement. Monitoring this helps investors assess the volatility and unrealized performance of a company's treasury or strategic investment holdings.